- Updated:10/28/21
- Country/Territory:U.S.
- Headquarters:Gaithersburg, Md.
- Industry:Pharmaceuticals
- CEO:Robert Kramer
- Website:https://www.emergentbiosolutions.com
- Ticker:EBS
- Company type:Public
- Revenues ($M):$1,706
- Profits ($M):$387
- Market value ($M):$2,743
- Number of employees:2,200
Revenue and net income for the four quarters ended on or before April 30, 2021. Market value as of Oct. 12, 2021.